Publications by authors named "Laura Forti"

Claim this Profile
A
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.
Carolina Sciortino, Federico Nichetti, Francesca Bergamo, Federica Palermo, Stefano Tamberi, Laura Forti

Dig Liver Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.
Francesco Leone, Valeria Fiamma, Francesca Crivelli, Myriam Katja Paris, Laura Giovanna Forti

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants.
Michele Milella, Giulia Orsi, Mariacristina di Marco, Lisa Salvatore, Letizia Procaccio, Laura Forti

Cancer Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of intrahepatic cholangiocarcinoma: a review for clinicians.
Matteo Colangelo, Marcello Di Martino, Michela Anna Polidoro, Laura Forti, Nastassja Tober

Gastroenterol Rep (Oxf)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review.
Andrea Brignoli, Eleonora Ferrara, Micol Zannetti, Gianfranco Loi, Laura Forti

Curr Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi, Marina Macchini, Laura Forti

Br J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.
Chiara Baratelli, Marco Tampellini, Massimo Di Maio, Azzurra Ottone, Maria Pia Brizzi, Laura Forti

Int J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Ewing's sarcoma of the sinonasal tract, eroding the ethmoid and sphenoid sinus with intracranial extension: A rare case report.
Maria Emanuela Negru, Andrea Pietro Sponghini, David Rondonotti, Francesca Platini, Marco Giavarra, Laura Forti

Mol Clin Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study.
Marco Tampellini, Azzurra Ottone, Elisa Bellini, Irene Alabiso, Chiara Baratelli, Laura Forti

Oncologist· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hypericum perforatum CO2 extract on the motivational properties of ethanol in alcohol-preferring rats.
Marina Perfumi, Laura Mattioli, Laura Forti, Maurizio Massi, Roberto Ciccocioppo

Alcohol Alcohol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis